Scarica l'app Stockscreener
2.39
2.58%
0.06
Dopo l'orario di chiusura:
2.37
-0.02
-0.84%
Precedente Chiudi:
$2.33
Aprire:
$2.38
Volume 24 ore:
646.28K
Relative Volume:
1.32
Capitalizzazione di mercato:
$161.96M
Reddito:
-
Utile/perdita netta:
$-64.20M
Rapporto P/E:
-1.1116
EPS:
-2.15
Flusso di cassa netto:
$57,000
1 W Prestazione:
+7.17%
1M Prestazione:
+37.36%
6M Prestazione:
+69.50%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.35
$2.43
Intervallo di 1 settimana:
$2.12
$2.49
Portata 52W:
$1.05
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
Nome
Climb Bio Inc
Settore
Industria
Telefono
1-866-857-2596
Indirizzo
20 WILLIAM STREET, WELLESLEY HILLS
Confronta CLYM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
2.39 | 157.89M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Iniziato | Robert W. Baird | Outperform |
| 2025-06-06 | Iniziato | Oppenheimer | Outperform |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
Climb Bio Inc Borsa (CLYM) Ultime notizie
What recovery options are there for Climb Bio Inc.2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Is Climb Bio Inc. a strong growth stockJuly 2025 Volume & Verified Chart Pattern Trade Signals - 더경남뉴스
Is Climb Bio Inc. stock poised for growthGold Moves & AI Driven Stock Movement Reports - Newser
Will Climb Bio Inc. stock recover after recent dropPortfolio Profit Report & Long Hold Capital Preservation Tips - Newser
How institutional ownership impacts Climb Bio Inc. stockJuly 2025 Trends & Long-Term Capital Growth Strategies - Newser
Climb Bio shares fall 1.29% after-hours following announcement of CLYM116 webcast event. - AInvest
Does Climb Bio Inc. have pricing powerJuly 2025 Rallies & Expert Approved Trade Ideas - خودرو بانک
What is Climb Bio Inc. s P E ratio telling usJuly 2025 Update & Weekly Breakout Stock Alerts - خودرو بانک
Climb Bio shares rise 2.05% premarket after announcing CLYM116 webcast event. - AInvest
Exit strategy if you’re trapped in Climb Bio Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025 - Yahoo Finance
Can Climb Bio Inc. sustain earnings growthWeekly Market Report & Entry Point Strategy Guides - خودرو بانک
Automated trading signals detected on Climb Bio Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
Multi factor analysis applied to Climb Bio Inc.Market Performance Recap & Verified Technical Trade Signals - Newser
Market reaction to Climb Bio Inc.’s recent newsQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
Is Climb Bio Inc. showing signs of accumulationJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
Statistical indicators supporting Climb Bio Inc.’s strengthPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
What MACD and RSI say about Climb Bio Inc.Analyst Downgrade & Weekly Setup with ROI Potential - Newser
Does Climb Bio Inc. have a sustainable dividend2025 Market WrapUp & Long Hold Capital Preservation Tips - khodrobank.com
What’s the outlook for Climb Bio Inc.’s sectorMarket Performance Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Is Climb Bio Inc. reversing from oversold territory2025 Short Interest & Growth Oriented Trading Recommendations - Newser
Is Climb Bio Inc. still worth holding after the dipWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Is Climb Bio Inc. stock forming a triangle patternJuly 2025 Big Picture & Real-Time Buy Signal Notifications - خودرو بانک
Order flow analysis tools used on Climb Bio Inc.Weekly Stock Summary & Proven Capital Preservation Methods - Newser
Will Climb Bio Inc. benefit from geopolitical trendsWeekly Profit Recap & Fast Moving Trade Plans - خودرو بانک
Applying chart zones and confluence areas to Climb Bio Inc.Portfolio Risk Report & Smart Swing Trading Alerts - Newser
Does Climb Bio Inc. outperform in volatile marketsTrade Analysis Summary & Free Accurate Trade Setup Notifications - خودرو بانک
What’s the analyst consensus on Climb Bio Inc.July 2025 Price Swings & Daily Price Action Insights - خودرو بانک
Is Climb Bio Inc. forming bullish engulfing patternsJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - خودرو بانک
Applying Wyckoff theory to Climb Bio Inc. stock2025 Winners & Losers & Verified Technical Signals - Newser
What MACD and RSI say about Climb Bio IncTrade Analysis Summary & Verified Entry Point Detection - Newser
Climb Bio Inc. Uptrend in Early Stages Indicators Say YesPortfolio Update Summary & High Return Stock Watch Alerts - beatles.ru
Evaluating Climb Bio Inc. with trendline analysis2025 Market Overview & Weekly High Return Opportunities - Newser
Climb Bio Inc. stock daily chart insights2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Pattern recognition hints at Climb Bio Inc. upsidePortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Is Climb Bio Inc. forming a reversal patternWall Street Watch & Long-Term Investment Growth Plans - Newser
Climb Bio Inc Azioni (CLYM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):